Stewart Parker Resigns from Board of Targeted Genetics, Susan Robinson Takes Her Spot

Xconomy Seattle — 

H. Stewart Parker has resigned from the board of Targeted Genetics, a week after she stepped down as president and CEO. The Seattle-based biotech company (NASDAQ: TGEN) named her replacement as CEO, Susan Robinson, to also fill Parker’s position on the board. Parker left the company she founded as a series of setbacks in the field of gene therapy put the company in a precarious position. Targeted Genetics stock closed Friday at 32 cents a share.